The U.S. Food and Drug Administration will take steps to streamline the process to develop generic versions of complex ...

The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative ...

It's the Trump administration's latest move to rein in high prescription drug costs in the U.S., and could be a blow to ...

The FDA said it proposed significant changes to simplify biosimilarity studies and reduce what it described as unnecessary ...

The Food and Drug Administration said it will be taking steps to speed up the approval process for developing generic biological drugs, an effort aimed at increasing cheaper competition among ...

The U.S. Food and Drug Administration (FDA) has announced major steps to make it faster and less costly to develop biosimilar medicines, lower-cost "generic" alternatives to biologic drugs used to ...

Mr. Funk was the managing editor of Pleroma Media, and worked as a breaking news reporter at The Messenger after spending 25 years at Fox Television as a producer, executive producer, and digital ...

In a groundbreaking move, the Trump administration is tackling the pressing issue of high healthcare costs by accelerating the development of affordable generic medications. In a press conference ...

There are three obstacles to faster development and deployment of non-addictive pain treatments. They are the business ...

Biologic medications, while accounting for only 5% of U.S. prescriptions, represent 51% of total drug spending in 2024. Despite FDA-approved biosimilars being as safe and effective as their branded ...

Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company to Manufacture Generic Tobramycin Inhalation Solution ...

The U.S. Food and Drug Administration (FDA) today announced action to make it faster and less costly to develop biosimilar ...